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stenosis in children and young adults is frequently encountered in
developing countries, and up to 25% of patients are younger than
20 years of age. This disease has been called juvenile mitral
stenosis.
Juvenile MS has been reported at very young age in the Indian
subcontinent.
We report a case of juvenile MS at 3 year age, the youngest ever
case reported
Clinical and hemodynamic profiles of
different etiologies of severe aortic
stenosis
S. Patil, G. Rege *, L. Anand, V.R. Iyer, P.K. Dash
H-105, H-Block, Sri Satya Sai Institute of Higher Medical Sciences,
Prasantigram 515134, District Anantapur, Andhra Pradesh, India
Aims and objectives: To study the correlation between clinical
presentation of severe aortic stenosis with echocardiographic
measurements of left ventricle function and aortic valvular hemo-
dynamics including LV strain amongst its etiologies.
Materials and methods: This study has been performed from June
2013 to December 2014 in cardiology department at Sri Sathya Sai
Institute of Higher Medical Sciences in Puttaparthi, Anantapur
(Andhra Pradesh). Study included patients of severe AS coming
to cardiology OPD and who were willing for the study and were
eligible as per inclusion criteria. (Severe AS is deﬁned as aortic
valve area (by continuity equation) <1 cm2.)
Results:Total number of patients in study is 102.Male constitute 71
(70%) and females 31 (30%).
Mean age of presentation of rheumatic AS group 44 years, for
bicuspid group is 25 years and for degenerative group is 59 years.
Main symptoms of patient in all etiologies are dyspnoea, bicuspid
group 96% rheumatic 100%, degenerative 72%. Angina as a pre-
dominant symptom was seen 21% of patients with degenerative
group. Syncope was seen in 3 patients only. One in biscuspid group
and 2 in degenerative group.
All three group of patients had average AVA (Bicuspid 0.73
 0.01 cm2 Rheumatic 0.76 0.12 cm2 Degenerative 0.74
 0.08 cm2) and AVAI (Bicuspid 0.58 0.3 cm2/m2 Rheumatic 0.48
 0.09 cm2/m2 Degenerative 0.46 0.03 cm2/m2) in the range of
severe AS.
The average PG for (Bicuspid 96  30 mm Hg Rheumatic 93
 29 mm Hg Degenerative 93  31) and MG (B 62 R 56  19 D 55
 16) in the range of severe AS.
LV dimentions and LVH comparisons in etiologies.
Bicuspid Rheumatic Degenerative P value
LVIDd, mm 43  7.17 59  6.71 47  6.7 0.006
LVIDs, mm 26  6.19 31  4.8) 32  6.98 0.001
LVSd, mm 13  2 14  1.9 14  2.3 0.005
LVPWd, mm 12  2 13  1.6 14  1.7 0.001
LVMI g/m2 137  13 148  12 155  9 0.001
Comparison between SVI, LVEF and GLS between etiologies.
Bicuspid Rheumatic Degenerative P value
SVI ml/m2 60  4 59  3 56  5.2 0.001
LVEF % 67  8 64  9 59  9 0.008
GLS % 18  6.4 16  5 16  4 0.421
Therewas statistically signiﬁcant difference between SVI and LVEF
among the three groups. SVI and LVEFwere higher in patients with
bicuspid group compared to rheumatic and degenerative group
which suggest relatively better preserved LV systolic function in
bicuspid group
LV GLS assessment results showed that GLS was decreased in all 3
group. Degenerative and rheumatic group have more decrease in
GLS compared to bicuspid group but statistically not signiﬁcant.
Conclusions:
1. The clinical spectrum of Aortic stenosis is broad. And
patients with the same AVA can have different clinical
proﬁle, intracardiac hemodynamics and symptoms.
2. Patients with bicuspid aortic valve presents early, mean age
24 years, have less degree of LVH, less systolic and diastolic
dysfunction.
3. While patientswith rheumatic ASmean age of presentation
was 44 years with predominant symptom as dyspnoea.
Have signiﬁcant degree of left ventricular hypertrophy and
diastolic dysfunction.
4. Degenerative AS group mean age of presentation was 59
years and most common symptom dyspnoea 72%. Have
signiﬁcantly more left ventricular hypertrophy and dia-
stolic dysfunction compared to other etiologies. They also
have more elevated LV ﬁlling pressures (E/e0) possibly
because of higher age of patients andmayhave preexisting
myocardial disease. Ischemic heart disease, diabetes
mellitus type 2, systemic hypertension are common in
this age group.
5. GLS assessment of patients with preserved LV systolic
function LVEF>50%. Showed signiﬁcant abnormality in GLS
suggestive of subclinical myocardial systolic dysfunction.
Emphases the recommendation for routine use of strain
assessment in patients of valvular AS.
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Background: Acenocoumarol, an oral vitamin K antagonist, is a
commonly prescribed anticoagulant following valve replacement
surgery in India and has a narrow therapeutic index. This study
aimed at investigating the prevalence of vitamin K 2,3 epoxide
reductase C1 (VKORC1) gene polymorphism in south Indian
patients and its inﬂuence on the inter-individual variability in
response to acenocoumarol therapy.
Methods: The study cohort included 205 rheumatic heart disease
patients with mechanical heart valves, on acenocoumarol therapy
with a stable therapeutic INR between 2 and 3.5. VKORC1 1639G>A
and 1173C>T genotypes were determined by PCR-RFLP method.
Correlation between genotypes and the acenocoumarol dosage
was evaluated.
Results: Themost prevalent genotypes of VKORC1 in our studywas
wild homozygous GG for-1639G>A and CC for 1173C>T (57.6%).
This was followed by heterozygous GA & CT at 36.1% and AA & TT
at 6.3%. The Allele frequency for both G and C was 0.76 and for A
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